Cargando…

Mirtazapine for symptom control in refractory gastroparesis

INTRODUCTION: Gastroparesis symptoms can be severe and debilitating. Many patients do not respond to currently available treatments. Mirtazapine has been shown in case reports to reduce symptoms in gastroparesis. AIM: To assess the efficacy and safety of mirtazapine in gastroparetic patients. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malamood, Mark, Roberts, Aaron, Kataria, Rahul, Parkman, Henry P, Schey, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384687/ https://www.ncbi.nlm.nih.gov/pubmed/28408802 http://dx.doi.org/10.2147/DDDT.S125743

Ejemplares similares

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Taste and Smell Disturbances in Patients with Gastroparesis and Gastroesophageal Reflux Disease
por: Kabadi, Alisha, et al.
Publicado: (2017)

Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study
por: Midani, Deena, et al.
Publicado: (2016)

Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment
por: Jehangir, Asad, et al.
Publicado: (2017)

Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit
por: Suri, Jaspreet, et al.
Publicado: (2018)

Distal Esophageal Impedance Measured by High-resolution Esophageal Manometry With Impedance Suggests the Presence of Barrett’s Esophagus
por: Kataria, Rahul, et al.
Publicado: (2020)

Post-Fundoplication Dumping Syndrome: A Frequent “Rare” Complication
por: Kataria, Rahul, et al.
Publicado: (2018)

A cross-sectional study describing peripheral neuropathy in patients with symptoms of gastroparesis: associations with etiology, gastrointestinal symptoms, and gastric emptying
por: Moors, Victoria J., et al.
Publicado: (2022)

Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis
por: McCallum, R W, et al.
Publicado: (2013)

Health‐care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis
por: Chen, Yaozhu J., et al.
Publicado: (2022)

Mirtazapine treatment of diabetic gastroparesis as a novel method to reduce tube-feed residual: a case report
por: Gooden, Janelle Y, et al.
Publicado: (2013)

Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience
por: Barbash, Benjamin, et al.
Publicado: (2019)

Effect of liquid and solid test meals on symptoms and gastric myoelectrical activity in patients with gastroparesis and functional dyspepsia
por: Koch, Kenneth L., et al.
Publicado: (2022)

The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
por: Revicki, Dennis A., et al.
Publicado: (2018)

COVID-19 infection manifesting as a severe gastroparesis flare: A case report
por: Song, Jun, et al.
Publicado: (2021)

Immunomodulation for treatment of drug and device refractory gastroparesis
por: Soota, Kaartik, et al.
Publicado: (2016)

Gastric peroral endoscopic myotomy for refractory gastroparesis
por: Elkholy, Shaimaa, et al.
Publicado: (2020)

Gastric Electrical Stimulation for Refractory Gastroparesis: A Promising Treatment Modality for Symptom Control and Gastric Emptying
por: Saeed, Shahzeb, et al.
Publicado: (2023)

Gastric Electrical Stimulation for Treatment of Refractory Gastroparesis: the Current Approach to Management
por: Shanker, Aaron, et al.
Publicado: (2021)

Ultrastructural differences between diabetic and idiopathic gastroparesis
por: Faussone-Pellegrini, Maria Simonetta, et al.
Publicado: (2012)

Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far
por: Gotfried, Jonathan, et al.
Publicado: (2017)

Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis
por: Siraj, Elias S., et al.
Publicado: (2018)

Clinical predictors of symptom improvement failure in gastroparesis
por: Amjad, Waseem, et al.
Publicado: (2022)

Pyloroplasty for Refractory Diabetic Gastroparesis After Renal Transplantation
por: Angelo, Jillian L., et al.
Publicado: (2015)

Postsurgical Refractory Gastroparesis: Response to Botulinum Toxin Therapy
por: Sarvepalli, Deepika, et al.
Publicado: (2020)

Prevalence of Hidden Gastroparesis in the Community: The Gastroparesis "Iceberg"
por: Rey, Enrique, et al.
Publicado: (2012)

Rectal Sensitivity in Diabetes Patients with Symptoms of Gastroparesis
por: Søfteland, Eirik, et al.
Publicado: (2014)

Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary
por: Fehnel, Sheri, et al.
Publicado: (2019)

Gastroparesis
por: Miles, Matthew, et al.
Publicado: (2023)

Gastroparésie
por: Miles, Matthew, et al.
Publicado: (2023)

Mirtazapine: A One-Stop Strategy for Treatment of Opioid Withdrawal Symptoms
por: Lalani, Elisha, et al.
Publicado: (2023)

Liraglutide-induced Acute Gastroparesis
por: Rai, Puja, et al.
Publicado: (2018)

Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial
por: Martinek, Jan, et al.
Publicado: (2022)

A Case of Mirtazapine-Induced Pancreatitis
por: Aslam, Hunain, et al.
Publicado: (2023)

Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)

Tachyphylaxis to the Sedative Action of Mirtazapine
por: Papazisis, Georgios, et al.
Publicado: (2018)

Mirtazapine for the Treatment of Chronic Pruritus
por: Khanna, Raveena, et al.
Publicado: (2019)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

Use of Mirtazapine and Olanzapine in the Treatment of Refractory Hyperemesis Gravidarum: A Case Report and Systematic Review
por: Galletta, Marco Aurélio Knippel, et al.
Publicado: (2022)

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l8l40k3pm4ioe23fodn04kk11b